The effects of transdermal insulin treatment of streptozotocin-induced diabetic rats on kidney function and renal expression of glucose transporters

References

• Group UKPDS, UK. Prospective diabetes study 16: Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes. 1995;44:1249–1258
   PubMedGoogle Scholar
• Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care. 2003;26:1589–1596
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 2002;288:2579–2588
   PubMed Web of Science ®Google Scholar
• Rabkin R. Diabetic nephropathy. Clin Cornerstone. 2003;5:1–11
   PubMedGoogle Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–986
   PubMed Web of Science ®Google Scholar
• Ohkubo YA, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–117
   PubMed Web of Science ®Google Scholar
• Bas VN, Setinkaya S, Agladioglu SY, et al. Insulin oedema in newly diagnosed type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2010;2:46–48
   PubMedGoogle Scholar
• Tufts M, Musabayane CT. Transdermal delivery of insulin using amidated pectin hydrogel patches. Society for Endocrinology BES. 2010;21:173
   Google Scholar
• Musabayane CT, Ndhlovu CE, Balment RJ. Renal fluid and electrolyte handling in streptozotocin induced diabetic rats. Ren Fail. 1995;17:107–116
   PubMed Web of Science ®Google Scholar
• Li Y, Higashiura K, Ura N, et al. Effects of the Chinese medicine, TSJN on insulin resistance and hypertension in fructose-fed rats, hypertension research. J JPN Soc Hypertens. 2000;23:101–107
   Google Scholar
• Haller H, Drab M, Luft FC. The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy. J Clin Nephrol. 1996;46:246–255
   PubMed Web of Science ®Google Scholar
• Krishnan R, Izatt S, Bargman JM, Oreopoulos D. Prevalence and determinants of erectile dysfunction in patients on peritoneal dialysis. Int Urol Nephrol. 2003;35:553–556
   PubMedGoogle Scholar
• Stengel B, Billion S, Van Dijk PC, et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe. Nephrol Dial Transplant. 2003;18:1824–1833
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, Defronzo RA. Lowering plasma glucose concentration by inhibiting renal sodium–glucose co-transport. J Int Med. 2014;276:352–363
   PubMed Web of Science ®Google Scholar
• Vestri S, Okamoto MM, Freitas HSD, et al. Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol. 2001;182:105–112
   PubMed Web of Science ®Google Scholar
• Marks J, Carvou NJ, Debnam ES, Srai SK, Unwin RJ. Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane. J Physiol. 2003;553:137–145
   PubMed Web of Science ®Google Scholar
• Dominguez JH, Camp K, Maianu L, Feister HW, Garvey TW. Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. Am J Physiol. 1994;266:F238–F290
   Google Scholar
• Musabayane CT, Munjeri O, Matavire TP. Transdermal delivery of chloroquine by amidated pectin hydrogel matrix patch in the rat. Ren Fail. 2003;25:525–534
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biochem. 1951;193:265–275
   Google Scholar
• Kumar A, RIlavarasan R, Jayachandran T, et al. Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. J Med Plants Res. 2008;2:246–249
   Google Scholar
• Krishnan JA, Parce PB, Martinez M, Dietz GB, Brower RG. Caloric intake in medical ICU patients: Consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003;124:297–305
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Macia M, Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study. J Am Soc Nephrol. 2006;17:S90–S97
   PubMed Web of Science ®Google Scholar
• Gnudi L, Thomas SM, Viberti G. Mechanical forces in diabetic kidney disease: A trigger for impaired glucose metabolism. J Am Soc Nephrol. 2007;18:2226–2232
   PubMed Web of Science ®Google Scholar
• Bloomgarden ZT. American college of endocrinology pre-diabetes consensus conference: Part three. Diabetes Care. 2008;31:2404–2409
   PubMedGoogle Scholar
• Kuramochi G, Homma S. Effects of furosemide on renal oxygen consumption after ischemia in normal and streptozotocin diabetic rats. Nephron Physiol. 1993;64:436–442
   Google Scholar
• Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216–226
   PubMed Web of Science ®Google Scholar
• Koulmanda M, Qipo A, Chebrolu S, et al. The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis). Am J Transplant. 2003;3:267–272
   Google Scholar
• Welsh GI, Hale LJ, Eremina V, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 2010;12:329–340
   PubMedGoogle Scholar
• Musabayane CT, Ndhlovu CE, Balment RJ. Renal fluid and electrolyte handling in streptozotocin induced diabetic rats. J Ren Fail. 1995;17:107–116
   PubMed Web of Science ®Google Scholar
• Musabayane CT, Tufts MA, Mapanga RF. Synergistic antihyperglycemic effects between plant-derived oleanolic acid and insulin in streptozotocin-induced diabetic rats. J Ren Fail. 2010;32:832–839
   PubMed Web of Science ®Google Scholar
• Mkhwanazi BN, Serumula MR, Myburg RB, Heerden FRV, Musabayane CT. Antioxidant effects of maslinic acid in livers, hearts and kidneys of streptozotocin-induced diabetic rats: Effects on kidney function. Ren Fail. 2014;36:419–431
   PubMed Web of Science ®Google Scholar
• Rostand SG, Watkins JB, Clements RS. The effect of insulin and of anti-insulin serum on handling of sodium by the isolated, perfused kidney of the streptozotocin-diabetic rat. Diabetes. 1980;29:679–685
   PubMedGoogle Scholar
• Allon M, Copknky C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int. 1990;38:869–872
   PubMed Web of Science ®Google Scholar
• Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int. 1993;43:1197–1209
   PubMed Web of Science ®Google Scholar
• Herlitz H, Widgren B, Urbanavicius V, Attvall S, Persson B. Stimulatory effect of insulin on tubular sodium reabsorption in normotensive subjects with a positive family history of hypertension. Nephrol Dial Transplant. 1996;11:47–54
   PubMedGoogle Scholar
• Hadebe SI, Ngubane PS, Serumula MR, Musabayane CT. Transdermal delivery of insulin by amidated pectin hydrogel matrix patch in streptozotocin-induced diabetic rats: Effects on some selected metabolic parameters. PLoS One. 2014;9:e101461
   PubMed Web of Science ®Google Scholar